Technology
Health
Medical

Qiagen

864

$45.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.76 (+1.71%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Qiagen and other stocks, options, ETFs, and crypto commission-free!

About QGEN

Qiagen NV, also called Qiagen, is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. Read More The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

CEO
Thierry Bernard
Employees
5,096
Headquarters
Venlo, Limburg
Founded
1996
Market Cap
10.34B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.15M
High Today
$45.39
Low Today
$44.62
Open Price
$44.74
Volume
1.47M
52 Week High
$45.39
52 Week Low
$25.04

Collections

Technology
Health
Medical
Europe (Non-UK)
Europe

QGEN News

Reuters7h

BRIEF-Davidson Kempner European Partners In Letter To Qiagen Says Believe Offer Of €39/Share From Thermo Fisher Scientific Is "Inadequate"

July 10 (Reuters) - Davidson Kempner European Partners: * DAVIDSON KEMPNER EUROPEAN PARTNERS SENDS LETTER TO QIAGEN NV * DAVIDSON KEMPNER EUROPEAN PARTNERS IN
0
Reuters8h

Qiagen shareholder Davidson Kempner says Thermo Fisher offer 'inadequate'

FILE PHOTO: Illustration of products are pictured from Qiagen, the diagnostics company which has agreed an $11.5 billion takeover deal with U.S-based Thermo Fis
0

QGEN Earnings

$0.00
$0.16
$0.32
$0.48
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Aug 4, After Hours

You May Also Like

TAOP
FXR
BRC
XENT
JPHY
LADR
NYMTN
EAGG
FPXI
VDE
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy QGEN

Market Price$45.31
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Qiagen stock and options commission-free.
LearnBlogCareersHelpLog InSign Up